CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,141,003 | -22.7% | 87,782 | 0.0% | 0.02% | -34.5% |
Q4 2022 | $2,768,644 | +11.6% | 87,782 | 0.0% | 0.03% | 0.0% |
Q3 2022 | $2,481,000 | -32.5% | 87,782 | -16.4% | 0.03% | -29.3% |
Q1 2022 | $3,676,000 | -70.7% | 105,000 | -75.3% | 0.04% | -73.5% |
Q3 2021 | $12,531,000 | -40.7% | 424,767 | -48.5% | 0.16% | -36.5% |
Q2 2021 | $21,121,000 | +51.9% | 824,389 | -18.6% | 0.24% | +36.3% |
Q1 2021 | $13,901,000 | -37.5% | 1,012,480 | -24.5% | 0.18% | -43.0% |
Q4 2020 | $22,242,000 | – | 1,341,485 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |